Incannex Healthcare Inc. Earnings Per Share (Basic)
Incannex Healthcare Inc. (IXHL) reported Earnings Per Share (Basic) of -$0.35 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-15
- Incannex Healthcare Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.35.
- Incannex Healthcare Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.02.
- Incannex Healthcare Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.02.
- Incannex Healthcare Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.23.
- Incannex Healthcare Inc. earnings per share, basic for fiscal 2025 was -$1.35.
- Incannex Healthcare Inc. earnings per share, basic for fiscal 2024 was -$1.15.
- Incannex Healthcare Inc. earnings per share, basic for fiscal 2023 was -$3.32.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.35 10-Q · filed 2026-05-15 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.51 10-Q · filed 2026-05-15 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-12-31 | -$0.02 10-Q · filed 2026-02-13 | -$0.04 10-Q · filed 2026-02-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-09-30 | -$0.02 10-Q · filed 2025-11-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-06-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.35 10-K · filed 2025-09-29 | ||
| 2025-03-31 | -$6.19 10-Q · filed 2026-05-15 | -$0.20 10-Q · filed 2025-05-15 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$25.39 10-Q · filed 2026-05-15 | -$0.84 10-Q · filed 2025-05-15 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | -$0.33 10-Q · filed 2026-02-13 | -$0.65 10-Q · filed 2026-02-13 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-09-30 | -$0.29 10-Q · filed 2025-11-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-06-30 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-09-29 | -$1.15 10-K · filed 2025-09-29 | ||
| 2024-03-31 | -$0.38 10-Q · filed 2025-05-15 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.76 10-Q · filed 2025-05-15 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||
| 2023-12-31 | -$0.33 10-Q · filed 2025-02-14 | -$0.38 10-Q · filed 2025-02-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-02-14 | $0.38 10-Q · filed 2024-02-14 | ||
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-09-30 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-09-30 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-09-30 | -$3.32 10-K · filed 2024-09-30 | ||
| 2023-03-31 | -$0.22 10-Q · filed 2024-05-15 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$2.93 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $0.05 10-Q · filed 2024-02-14 | -$2.76 10-Q · filed 2024-02-14 | $2.76 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |